Depressive Stupor: Emergency Assessment, Treatment and Nursing Care

Depressive Stupor: Emergency Assessment, Treatment and Nursing Care

Depressive stupor is a severe, potentially life-threatening state in which a person with a depressive illness becomes markedly immobile, mute or minimally responsive and unable to initiate ordinary activity, despite appearing awake. In modern clinical practice, many such patients are assessed for catatonia associated with a severe depressive episode. Stupor is a clinical sign rather than a complete diagnosis, and it must never be assumed to be “refusal,” stubbornness, sleep or attention-seeking.

The condition is a psychiatric and medical emergency. The same presentation can occur with delirium, seizures, encephalitis, metabolic disturbance, poisoning, medicine effects, neurological disease, psychosis and other forms of catatonia. Immobility and failure to eat or drink can rapidly lead to dehydration, malnutrition, aspiration, pressure injury, venous thromboembolism, infection, kidney injury and death. Assessment of airway, breathing, circulation, consciousness, temperature, glucose and other urgent medical causes therefore comes before a long psychiatric interview.

Learning Objectives

By the end of this lesson, the learner should be able to:

• Define depressive stupor and explain its relationship to severe depression and catatonia.
• Recognise stupor, mutism, negativism, posturing and other catatonic signs.
• Distinguish depressive stupor from reduced consciousness, delirium, neurological disease, medicine effects and other important differentials.
• Perform an urgent, systematic physical, neurological and psychiatric assessment.
• Describe appropriate investigations and the nursing responsibilities attached to them.
• Explain immediate supportive care, prescribed benzodiazepine treatment, treatment of the underlying depression and the role of electroconvulsive therapy.
• Develop a detailed nursing care plan that prevents dehydration, malnutrition, aspiration, pressure injury, thrombosis, infection and loss of function.
• Assess suicide risk, capacity, consent, safeguarding and family involvement without violating the patient’s rights.
• Identify recovery indicators, discharge needs and relapse-prevention measures.

Key Terms

Understanding Depressive Stupor

The traditional term “depressive stupor” describes the extreme end of psychomotor inhibition in severe depression. The patient may sit or lie almost motionless, speak little or not at all, fail to eat and drink, and appear disconnected from the environment. However, the person may remain conscious and may later remember conversations or events. Staff should therefore explain every intervention, preserve privacy and avoid humiliating remarks.

Modern assessment asks two linked questions:

1. Is there a severe depressive episode? Look for persistent low mood, loss of interest or pleasure, hopelessness, guilt, reduced energy, sleep and appetite disturbance, impaired concentration, psychotic symptoms, self-neglect and suicidal thinking.
2. Is there a catatonic syndrome? Look systematically for abnormal movement and responsiveness rather than relying only on “the patient is not talking.” A patient may have several signs, and the pattern can change from stupor to agitation.

The label should not be applied until urgent medical causes have been considered. Catatonia may occur with depression, bipolar disorder, schizophrenia-spectrum illness, autism, postpartum mental illness, infections, autoimmune encephalitis, epilepsy, endocrine or metabolic disease, neurological lesions, toxins, medicine reactions and withdrawal states.

Causes and Associated Conditions

Pathophysiology

No single mechanism explains every case. Catatonia is understood as dysfunction within brain networks that regulate initiation and inhibition of movement, emotion, attention and response to the environment. Research implicates altered gamma-aminobutyric acid (GABA), glutamate and dopamine signalling, together with motor-cortical and subcortical network abnormalities. This helps explain why a benzodiazepine such as lorazepam, which enhances GABA activity, can produce a rapid improvement in some patients and why electroconvulsive therapy can be effective in severe or persistent cases.

In severe depression, marked psychomotor inhibition may progress from slowed thought and movement to near-complete loss of spontaneous activity. Once the person becomes immobile and stops eating or drinking, a second harmful cycle begins:

• Reduced intake causes dehydration, electrolyte disturbance, hypoglycaemia and kidney injury.
• Immobility causes pressure injury, muscle wasting, contractures, constipation and venous stasis.
• Poor swallowing and weak protective responses increase aspiration and pneumonia risk.
• Incontinence, retention and poor hygiene increase skin and urinary infection risk.
• Medical complications can worsen consciousness, delirium and catatonic features, creating a dangerous feedback loop.

Clinical Manifestations

Features of the Underlying Depressive Illness

• Pervasive low mood: sadness, emptiness or emotional numbness may have been present before speech and movement reduced.
• Anhedonia: loss of interest or pleasure in previously meaningful work, relationships, worship, study or self-care.
• Hopelessness and guilt: the person may believe they are worthless, sinful, ruined or a burden; beliefs may reach delusional intensity.
• Biological symptoms: disturbed sleep, reduced appetite, weight loss, low energy, loss of libido and diurnal mood variation.
• Cognitive symptoms: poor concentration, indecision, slowed thought and reduced memory efficiency.
• Suicidality: thoughts, plans, previous attempts, concealed means, refusal of life-sustaining intake or severe self-neglect may be present even when the patient is silent.
• Psychotic depression: mood-congruent delusions, accusatory voices, nihilistic beliefs or beliefs that eating is forbidden or harmful.

Catatonic and Stuporous Features

Red Flags for Malignant Catatonia or Medical Deterioration

• Fever or rapidly changing temperature.
• Tachycardia, labile or high blood pressure, sweating or other autonomic instability.
• Increasing rigidity, agitation or altered level of consciousness.
• Hypoxia, breathing difficulty, choking, vomiting or suspected aspiration.
• No meaningful fluid intake, falling urine output or signs of severe dehydration.
• New seizure, focal neurological deficit, severe headache or rapidly evolving confusion.
• Dark urine, muscle tenderness, marked weakness or laboratory evidence suggesting rhabdomyolysis.
• Leg swelling, chest pain, unexplained breathlessness or collapse suggesting venous thromboembolism.
• Recent dopamine-blocking medicine exposure, dose increase or depot injection with fever and rigidity.

Emergency Assessment

Assessment and supportive treatment occur together. Obtain collateral history from family, caregivers, emergency staff and records, but address the patient directly and preserve confidentiality. A structured catatonia scale, such as the Bush–Francis Catatonia Rating Scale, may support recognition and monitoring when clinicians are trained to use it. It complements rather than replaces medical assessment.

Differential Diagnosis

Investigations

No blood test alone diagnoses depressive stupor or catatonia. Investigations identify physical complications, alternative causes and treatment risks. Selection depends on history, examination, age, pregnancy possibility, clinical severity and available resources.

• Immediate bedside tests: blood glucose, oxygen saturation, temperature and repeated vital signs identify hypoglycaemia, hypoxia, infection and autonomic instability.
• Full blood count: may show infection, anaemia or haemoconcentration from dehydration.
• Electrolytes, urea and creatinine: assess dehydration, sodium or potassium disturbance and kidney injury; trends guide fluid care.
• Liver function and glucose profile: help identify metabolic disease and treatment implications.
• Creatine kinase and urinalysis: indicated when rigidity, prolonged immobility, fever or dark urine raises concern for muscle injury or rhabdomyolysis.
• Inflammatory and infection tests: cultures, malaria testing, HIV-related assessment, chest imaging or other tests should follow symptoms, examination and local protocols rather than being ordered mechanically.
• Thyroid and other endocrine tests: considered where history or examination suggests thyroid, adrenal or other endocrine disorder.
• Toxicology and medicine levels: guided by exposure, overdose risk, substance use and prescribed treatment.
• Pregnancy test: where biologically relevant and consent or the lawful emergency pathway allows, because pregnancy affects investigation and treatment planning.
• Electrocardiogram: assesses rhythm, electrolyte effects and baseline risk before medicines or ECT when indicated.
• Electroencephalogram: helps exclude non-convulsive status epilepticus and may be important in unexplained or fluctuating unresponsiveness.
• Brain imaging: computed tomography or magnetic resonance imaging is considered for first episodes, focal signs, head injury, seizures, atypical course or suspected structural disease.
• Lumbar puncture and autoimmune or infectious studies: may be required when encephalitis, central nervous system infection or autoimmune disease is suspected, after appropriate safety assessment.

Management of Depressive Stupor

Aims of Management

• Preserve life and stabilise airway, breathing and circulation.
• Identify and treat medical, neurological, toxic and psychiatric causes.
• Recognise and treat catatonia early.
• Prevent dehydration, malnutrition, aspiration, thrombosis, infection, pressure injury and contractures.
• Treat the underlying depressive episode and any psychotic symptoms safely.
• Protect the patient from suicide, neglect, abuse and loss of dignity.
• Restore communication, movement, nutrition, self-care and meaningful function.

1. Immediate and First-Contact Care

1. Call for urgent clinical assistance and use an emergency-capable setting. A patient with absent intake, abnormal vital signs, reduced consciousness, fever, rigidity, hypoxia, seizure or suspected poisoning requires rapid medical evaluation.
2. Stabilise ABCDE abnormalities. Position the airway safely, give oxygen when clinically indicated, treat hypoglycaemia according to protocol, establish monitoring and obtain intravenous access when prescribed and necessary.
3. Reduce stimulation without isolating the patient. Use a calm area, one speaker, short explanations and gentle examination. Avoid a crowd of relatives or students repeatedly demanding a response.
4. Do not force food, fluid or oral medicine. Assess wakefulness and swallowing first. Forced oral intake can cause aspiration.
5. Begin a complication-prevention plan immediately. Record baseline skin, hydration, intake, output, mobility, calf findings, swallowing, bladder and bowel status; start prescribed prevention measures without waiting for the final psychiatric label.
6. Protect against self-harm. Search and secure dangerous items according to policy, use the least restrictive observation needed, and remember that mobility may return before hopelessness resolves.

2. Treat Reversible Physical Causes

Correct hypoglycaemia, hypoxia, dehydration, electrolyte disturbance, infection, poisoning, withdrawal or other identified causes using the appropriate medical protocol. Review all medicines. If neuroleptic malignant syndrome, malignant catatonia or another serious drug reaction is suspected, immediately escalate to an authorised prescriber and emergency medical team. Do not independently add or repeat sedating or dopamine-blocking medicines merely because the patient is difficult to assess.

3. Lorazepam Challenge and Benzodiazepine Treatment

A lorazepam challenge may support diagnosis and begin treatment when catatonia is suspected. Evidence-based catatonia guidance commonly describes a clinician-prescribed dose of lorazepam 1–2 mg intravenously or intramuscularly, or 2 mg orally, followed by structured reassessment; timing depends on the route. A clear reduction in catatonic signs supports the diagnosis, but absence of immediate improvement does not exclude it.

If there is benefit, the authorised specialist may prescribe scheduled lorazepam and titrate according to response and tolerability. The dose required varies widely. Monitor for excessive sedation, respiratory depression, falls, paradoxical agitation and loss of swallowing safety. Abrupt discontinuation after ongoing treatment may cause withdrawal or recurrence; tapering is clinician-directed.

4. Electroconvulsive Therapy

Electroconvulsive therapy (ECT) is a major treatment for severe catatonia and can also treat the underlying severe depressive illness. It should be considered urgently by a specialist team when the condition is life-threatening, when a rapid response is required because the patient is not eating or drinking, when malignant catatonia is suspected, or when adequate benzodiazepine treatment has not produced sufficient improvement.

ECT is performed under general anaesthesia with muscle relaxation and physiological monitoring. It is not the unmodified or punitive procedure sometimes portrayed in films. Assessment includes indication, expected benefit, alternatives, anaesthetic and medical risk, capacity and consent or the applicable lawful pathway. In Uganda, clinicians must follow the current Mental Health Act, professional standards and facility procedures. Nurses prepare the patient according to the local ECT protocol, verify prescribed fasting and investigations, provide pre- and post-anaesthetic care, monitor orientation and physical recovery, document effects and support the patient and family with accurate information.

5. Treatment of the Underlying Depression

• Antidepressant treatment: selected and prescribed according to diagnosis, severity, previous response, suicide risk, bipolar history, physical health, interactions, pregnancy and local guidance. Antidepressants do not replace urgent treatment of life-threatening catatonia.
• Psychotic depression: may require specialist combined treatment or ECT. Active catatonia changes the risk–benefit assessment of antipsychotics, so these medicines should not be started casually.
• Bipolar depression: requires a bipolar-specific plan; antidepressant monotherapy can be inappropriate for some patients. Ask about previous elevated mood, reduced need for sleep, overactivity and risky behaviour.
• Psychological support: during stupor, use simple reassuring communication and orientation. Structured psychotherapy becomes more useful as speech, concentration and energy return.
• Social intervention: address violence, bereavement, debt, housing, caregiving, academic or occupational stress and other maintaining factors without suggesting that social stress alone explains the emergency.

6. Caution with Antipsychotic Medicines

Catatonia is a risk factor for neuroleptic malignant syndrome. Dopamine-blocking antipsychotics can sometimes worsen catatonia, particularly when the patient is dehydrated, rigid, febrile or medically unstable. Their use may be appropriate later for a confirmed underlying psychotic disorder, but only after specialist risk–benefit assessment, treatment of catatonia and close monitoring. Never administer extra antipsychotic medication simply to “wake” a withdrawn patient.

Comprehensive Nursing Care

Therapeutic Communication: What to Say and Avoid

Nursing Process and Priority Problems

Priority Nursing Problems

• Risk of aspiration related to reduced responsiveness or impaired swallowing.
• Deficient fluid volume related to markedly reduced oral intake.
• Imbalanced nutrition: less than body requirements.
• Impaired physical mobility with risk of pressure injury, thrombosis and contracture.
• Impaired verbal communication related to mutism and psychomotor inhibition.
• Self-care deficit affecting hygiene, toileting, feeding and dressing.
• Risk of suicide or self-harm related to severe depression, hopelessness or psychosis.
• Risk of infection related to aspiration, immobility, poor intake, incontinence or invasive devices.
• Caregiver anxiety and knowledge deficit related to sudden severe behavioural change.

Examples of Measurable Outcomes

• Airway remains patent, oxygenation stays within the patient’s prescribed target and no aspiration signs develop.
• Hydration improves as shown by clinical examination, urine output and laboratory trends.
• The patient receives the prescribed nutritional requirement without aspiration or dangerous refeeding disturbance.
• Skin remains intact, limbs retain functional range and no evidence of venous thromboembolism develops.
• Catatonic signs reduce on repeated structured assessment after treatment.
• The patient uses speech, gesture, writing or another agreed method to communicate essential needs.
• Suicide risk is repeatedly assessed and managed, and the patient and supporters know the crisis pathway before discharge.

Complications

Special Populations

Pregnancy and the Postpartum Period

Catatonia or depressive stupor during pregnancy or after childbirth threatens both the patient and, where relevant, the fetus or infant through dehydration, malnutrition, immobility, suicide risk and inability to provide safe care. Obtain urgent joint psychiatric, obstetric, medical and anaesthetic input. ECT may be considered by specialists for severe depression or catatonia when physical health is at serious risk. Breastfeeding, infant safety, sleep, medicines and family support require an individual plan.

Older Adults

Medical causes, delirium, neurological disease, polypharmacy and frailty are especially important. Presentation may be mislabelled as dementia or “giving up.” Use cautious medicine dosing, protect against falls and aspiration, check hearing and vision, obtain baseline cognitive and functional information, and investigate acute change.

Children and Adolescents

Catatonia can occur in young people, including those with mood disorders, psychosis, autism or medical disease. Developmental baseline, regression, infection, seizures and medicine exposure must be assessed. Management requires a specialist child and adolescent team. ECT is used only in exceptional severe or life-threatening situations within an experienced specialist service and lawful framework.

People with Communication or Developmental Disabilities

Identify the person’s usual speech, movement, self-care, sensory pattern and preferred communication. A change from baseline is crucial. Use familiar supporters appropriately, visual aids and extra processing time while avoiding the assumption that all reduced interaction belongs to the pre-existing disability.

Monitoring Recovery

Recovery can be rapid after effective catatonia treatment or gradual as the underlying illness improves. Record specific change rather than “better.” Indicators include:

• more spontaneous eye movement, facial expression and purposeful movement;
• response to name or simple instruction with less delay;
• return of speech, gesture or writing;
• reduced rigidity, negativism, staring or posturing;
• safer swallowing and improved oral intake;
• participation in washing, dressing, toileting and mobility;
• stable temperature, pulse, blood pressure, hydration and laboratory findings;
• ability to describe mood, psychotic experiences, treatment preferences and suicide risk;
• renewed interest in relationships, daily routine and future plans.

Discharge, Rehabilitation and Relapse Prevention

Discharge should occur only after medical stability, adequate intake or a safe nutrition plan, manageable suicide risk, a clear treatment plan and realistic support arrangements. The patient should not be discharged merely because they have started speaking.

• Diagnosis and explanation: give the patient and chosen supporters understandable information about severe depression, catatonia, uncertainty and recovery.
• Medicine plan: provide names, purpose, dose, timing, important adverse effects and what to do after a missed dose. Warn against abrupt benzodiazepine or other treatment discontinuation.
• ECT continuation or maintenance plan: where prescribed, explain appointments, transport, fasting instructions, support and whom to call about complications.
• Physical recovery: continue nutrition, hydration, mobility, pressure-area care and management of any thrombosis, infection or organ injury.
• Early warning signs: slowing, reduced speech, staring, unusual postures, poor intake, sleeplessness, severe guilt, withdrawal, missed medicines, suicidal ideas or psychotic beliefs.
• Crisis thresholds: same-day or emergency review for absent intake, renewed mutism or immobility, fever, rigidity, confusion, seizure, suicide intent, poisoning or inability of carers to keep the person safe.
• Follow-up: arrange psychiatry and relevant medical review before discharge, with a named service, date, transport plan and backup contact.
• Rehabilitation: grade return to self-care, family roles, study and work; avoid both abandonment and unnecessary dependence.
• Family support: teach calm communication and realistic assistance. Relatives should not force food, restrain, secretly medicate or delay emergency care for prayer or traditional treatment alone.

Documentation and Handover

• Onset, time course and collateral sources.
• ABCDE findings, vital-sign trends, glucose and neurological observations.
• Objective catatonic signs and structured score where used.
• Mood, psychosis, suicide and safeguarding findings, including limitations caused by mutism.
• Food, fluid, urine, stool, weight, swallowing and skin assessment.
• Medicine and substance timeline, allergies and suspected adverse reactions.
• Investigations ordered, specimens obtained, results, actions and outstanding tests.
• Treatment given, route, exact time, observations before and after, response and adverse effects.
• Capacity, consent, information shared and the legal or emergency basis for treatment where relevant.
• Pressure care, VTE prevention, mobility, hygiene, oral care and family communication.
• Named escalation plan and changes requiring urgent medical or psychiatric review.

Common Errors and Safer Practice

Worked Clinical Example

Situation: A 34-year-old woman is brought by her sister after two months of worsening depression and four days of almost no speech, food or fluid. She sits motionless, stares, resists attempts to move her arm and has passed little urine. Her sister reports hopeless statements and a recent belief that she does not deserve to eat. An antipsychotic was started at another clinic two days earlier because she was thought to be psychotic.

Assessment Priorities

• Call senior medical and psychiatric staff and perform ABCDE assessment.
• Check glucose, oxygen saturation, temperature, pulse, blood pressure, hydration, consciousness and neurological signs.
• Assess swallowing before any oral intake and begin strict intake and output measurement.
• Document stupor, mutism, staring, negativism and withdrawal using a structured catatonia assessment where available.
• Obtain a complete medicine timeline and urgently review the recent dopamine-blocking medicine.
• Assess suicide risk using collateral evidence, previous history, available means and the depressive delusion about food.
• Investigate dehydration, electrolyte disturbance, infection, muscle injury, seizure and other medical or neurological causes as indicated.

Management and Nursing Care

1. Admit to an area capable of close medical observation and protect the airway, circulation and safety.
2. Correct dehydration and metabolic abnormalities through the prescribed route; use safe nutrition planning after swallowing and refeeding-risk assessment.
3. Begin pressure-area, VTE, oral-care, elimination and mobility precautions.
4. The authorised clinician performs a monitored lorazepam challenge. The nurse records baseline catatonic and respiratory findings, exact administration time and objective response.
5. If catatonia persists or the patient remains medically endangered by absent intake, the specialist team urgently considers ECT within the lawful consent or emergency framework.
6. Continue treatment of the severe depressive episode, including psychotic symptoms, with specialist caution regarding antipsychotic exposure during active catatonia.
7. As the patient begins moving and speaking, repeat suicide assessment; do not assume that motor improvement means the hopelessness has resolved.
8. Before discharge, provide a written relapse plan covering reduced speech, poor intake, posturing, severe guilt, medicine changes, urgent contacts and caregiver limits.

Key Examination Points

• Depressive stupor is severe psychomotor unresponsiveness associated with depression; many cases require assessment for catatonia.
• Stupor is a sign, not a final diagnosis, and medical or neurological causes must be excluded urgently.
• The patient may be awake and later remember what was said; maintain dignity and explain care.
• Key catatonic signs include stupor, mutism, staring, negativism, posturing, rigidity, withdrawal, stereotypy, echolalia and echopraxia.
• Fever, autonomic instability, worsening rigidity or altered consciousness suggests malignant catatonia or another medical emergency.
• Major complications are dehydration, malnutrition, aspiration, pressure injury, thrombosis, infection, contractures, rhabdomyolysis and renal injury.
• First management priorities are ABCDE stabilisation, glucose, physical assessment and urgent senior medical and psychiatric review.
• A lorazepam challenge is a prescribed and monitored diagnostic–therapeutic procedure; improvement supports catatonia.
• ECT is an important treatment when catatonia or severe depression is life-threatening, requires a rapid response or has not adequately responded to other treatment.
• Antipsychotics require specialist caution in active catatonia because of possible worsening and neuroleptic malignant syndrome risk.
• Nursing care actively protects airway, hydration, nutrition, skin, mobility, circulation, elimination, communication, dignity and safety.
• Repeat suicide assessment as movement returns because ability to act may improve before hopelessness resolves.

Revision Questions and Answers

1. What is depressive stupor?

It is a severe state associated with depressive illness in which the person becomes markedly immobile, mute or minimally responsive and unable to initiate ordinary activity despite appearing awake. Many patients require assessment for catatonia.

2. Why is depressive stupor an emergency?

It may be caused by serious medical, neurological, toxic or psychiatric illness, and immobility with absent intake can cause dehydration, aspiration, malnutrition, thrombosis, pressure injury, infection, renal injury and death.

3. Mention eight catatonic features.

Stupor, mutism, staring, negativism, posturing, catalepsy, waxy flexibility, rigidity, withdrawal, stereotypy, echolalia and echopraxia are examples.

4. What is the first assessment priority?

Perform ABCDE assessment with vital signs, glucose, consciousness and urgent treatment of physiological abnormalities before assuming a psychiatric cause.

5. What is a lorazepam challenge?

It is a clinician-prescribed, monitored administration of lorazepam followed by structured reassessment of catatonic signs. Rapid improvement supports the diagnosis and guides treatment, although no immediate response does not completely exclude catatonia.

6. When may ECT be considered?

ECT may be considered by a specialist team when catatonia or severe depression is life-threatening, a rapid response is needed because of absent intake or other severe risk, malignant catatonia is suspected, or adequate treatment has not produced sufficient improvement.

7. Why should antipsychotics be used cautiously?

Active catatonia increases vulnerability to worsening and neuroleptic malignant syndrome. Antipsychotic use should be based on specialist assessment of the underlying disorder, medical stability and treatment response.

8. State six nursing priorities.

Close physiological observation, airway and swallowing safety, hydration, nutrition, pressure-area care, VTE prevention, mobility and range of motion, elimination, hygiene, therapeutic communication, suicide prevention and accurate documentation are priorities.

9. How should the nurse communicate with a mute patient?

Introduce oneself, explain every action, use one short question at a time, allow long response time and offer gesture, nodding, pointing or writing. Never assume the patient cannot hear or understand.

10. Why must suicide risk be reassessed during recovery?

Movement and energy may improve before hopelessness, guilt or suicidal intent resolves, giving the patient greater ability to act on thoughts that were previously concealed by stupor.

References

1. Rogers JP, Oldham MA, Fricchione G, et al. Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology. 2023;37(4):327–369. Full guideline.
2. Rogers JP, Pollak TA, Blackman G, David AS. The diagnosis and treatment of catatonia. Clinical Medicine. 2023. Clinical guidance.
3. World Health Organization. Mental Health Gap Action Programme guideline for mental, neurological and substance use disorders. Third edition. 2023. WHO mhGAP guideline.
4. World Health Organization. mhGAP Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings. Version 2.0. WHO mhGAP Intervention Guide.
5. National Institute for Health and Care Excellence. Depression in adults: treatment and management. NICE guideline NG222. NICE recommendations.
6. National Institute for Health and Care Excellence. Guidance on the use of electroconvulsive therapy. Technology appraisal TA59. NICE ECT guidance.
7. Uganda Legal Information Institute. Mental Health Act, Chapter 308. Consolidated text. Uganda Mental Health Act.

Educational note: These notes support nursing revision and do not replace immediate patient assessment, authorised clinical orders, current Ugandan law, Ministry of Health guidance or facility procedures. Stupor, catatonia, absent intake, fever, rigidity, suicide risk and reduced consciousness require urgent professional evaluation.